Gullo, Charlotte ✱; Université de Liège - ULiège > GIGA > GIGA Cancer - Metastases Research Laboratory
Laverdeur, Emilie ✱; Université de Liège - ULiège > GIGA > GIGA Cancer - Metastases Research Laboratory
Dancre, Manon
Peiffer, Raphaël ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Biologie dans le domaine des sciences médicales et biomédicales
Agirman, Ferman ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques
Maloujahmoum, Naïma ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques ; Université de Liège - ULiège > Département des sciences précliniques BP > GIGA-R : Labo de recherche sur les métastases
Filho AM et al. The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwide Int. J. Cancer 2025 156 1336 1346 10.1002/ijc.35278 39688499
Bussetty A et al. Incidence of pancreas and colorectal adenocarcinoma in the US JAMA Netw. Open 2025 8 e254682 10.1001/jamanetworkopen.2025.4682 40227685 11997727
Turtoi A et al. Identification of novel accessible proteins bearing diagnostic and therapeutic potential in human pancreatic ductal adenocarcinoma J. Proteome Res. 2011 10 4302 4313 1:CAS:528:DC%2BC3MXpsFSrs7g%3D 10.1021/pr200527z 21755970
Fahmy K et al. Myoferlin plays a key role in VEGFA secretion and impacts tumor-associated angiogenesis in human pancreas cancer Int. J. Cancer 2016 138 652 663 1:CAS:528:DC%2BC2MXhsVGms77L 10.1002/ijc.29820 26311411
Rademaker G et al. Myoferlin controls mitochondrial structure and activity in pancreatic ductal adenocarcinoma, and affects tumor aggressiveness Oncogene 2018 66 1 15
Wang WS et al. ITRAQ-based quantitative proteomics reveals myoferlin as a novel prognostic predictor in pancreatic adenocarcinoma J. Proteomics 2013 91 453 465 1:CAS:528:DC%2BC3sXhslCls7zO 10.1016/j.jprot.2013.06.032 23851313
Bernatchez PN Sharma A Kodaman P Sessa WC Myoferlin is critical for endocytosis in endothelial cells Am. J. Physiol. Cell Physiol. 2009 297 C484 92 1:CAS:528:DC%2BD1MXht1yktbrO 10.1152/ajpcell.00498.2008 19494235 2740391
Zhang T et al. A small molecule targeting myoferlin exerts promising anti-tumor effects on breast cancer Nat. Commun. 2018 9 3726 2018NatCo..9.3726Z 10.1038/s41467-018-06179-0 30213946 6137146
Li Y et al. Modification and biological evaluation of a series of 1,5-diaryl-1,2,4-triazole compounds as novel agents against pancreatic cancer metastasis through targeting myoferlin J. Med. Chem. 2019 62 4949 4966 2019pso.book...L 1:CAS:528:DC%2BC1MXosVOhsLs%3D 10.1021/acs.jmedchem.9b00059 31026162
He Y et al. A potent and selective small molecule inhibitor of myoferlin attenuates colorectal cancer progression Clin. Transl. Medicine 2021 11 e289 1:CAS:528:DC%2BB3MXlvVygurs%3D 10.1002/ctm2.289
Gu H et al. Discovery of 1,5-diaryl-1,2,4-triazole derivatives as myoferlin inhibitors and their antitumor effects in pancreatic cancer Futur. Med. Chem. 2022 14 1425 1440 1:CAS:528:DC%2BB38Xis1Gnt7zJ 10.4155/fmc-2022-0168
Rademaker G et al. Myoferlin contributes to the metastatic phenotype of pancreatic cancer cells by enhancing their migratory capacity through the control of oxidative phosphorylation Cancers 2019 11 853 1:CAS:528:DC%2BB3cXjtlCktr0%3D 10.3390/cancers11060853 31248212 6628295
Rademaker G et al. Myoferlin targeting triggers mitophagy and primes ferroptosis in pancreatic cancer cells Redox Biol. 2022 53 102324 1:CAS:528:DC%2BB38Xht1ansbrJ 10.1016/j.redox.2022.102324 35533575 9096673
Li J et al. Small molecule MMRi62 induces ferroptosis and inhibits metastasis in pancreatic cancer via degradation of ferritin heavy chain and mutant p53 Mol. Cancer Ther. 2022 21 535 545 1:CAS:528:DC%2BB38Xht1equ7rF 10.1158/1535-7163.MCT-21-0728 35131878 10258866
Raphael BJ et al. Integrated genomic characterization of pancreatic ductal adenocarcinoma Cancer Cell 2017 32 185 203.e13 10.1016/j.ccell.2017.07.007
Anania S et al. Identification of myoferlin as a mitochondria-associated membranes component required for calcium signaling in PDAC cell lines Cell Commun. Signal. 2024 22 133 1:CAS:528:DC%2BB2cXktVOlsLY%3D 10.1186/s12964-024-01514-z 38368370 10874564
Wu M et al. Development and validation of a metastasis-related gene signature for predicting the overall survival in patients with pancreatic ductal adenocarcinoma J. Cancer 2020 11 6299 6318 1:CAS:528:DC%2BB3cXisFGjtLjO 10.7150/jca.47629 33033514 7532518
Barnhouse VR et al. Myoferlin regulates epithelial cancer cell plasticity and migration through autocrine TGF-β1 signaling Oncotarget 2018 9 19209 19222 10.18632/oncotarget.24971 29721195 5922389
Zaidel-Bar R Milo R Kam Z Geiger B A paxillin tyrosine phosphorylation switch regulates the assembly and form of cell-matrix adhesions J. Cell Sci. 2007 120 137 148 1:CAS:528:DC%2BD2sXht1Gmsb4%3D 10.1242/jcs.03314 17164291
Woodrow MA Woods D Cherwinski HM Stokoe D McMahon M Ras-induced serine phosphorylation of the focal adhesion protein paxillin is mediated by the Raf→MEK→ERK pathway Exp. Cell Res. 2003 287 325 338 1:CAS:528:DC%2BD3sXkvFGhtLs%3D 10.1016/S0014-4827(03)00122-8 12837288
Cortesio CL Boateng LR Piazza TM Bennin DA Huttenlocher A Calpain-mediated proteolysis of paxillin negatively regulates focal adhesion dynamics and cell migration J. Biol. Chem. 2011 286 9998 10006 1:CAS:528:DC%2BC3MXjsVyqt7s%3D 10.1074/jbc.M110.187294 21270128 3060554
Turtoi A et al. Myoferlin is a key regulator of EGFR activity in breast cancer Cancer Res. 2013 73 5438 5448 1:CAS:528:DC%2BC3sXhtlKkurbK 10.1158/0008-5472.CAN-13-1142 23864327
Nürnberg A Kitzing T Grosse R Nucleating actin for invasion Nat. Rev. Cancer 2011 11 177 187 10.1038/nrc3003 21326322
Yadav T Gau D Roy P Mitochondria–actin cytoskeleton crosstalk in cell migration J. Cell Physiol. 2022 237 2387 2403 1:CAS:528:DC%2BB38XotlGmu74%3D 10.1002/jcp.30729 35342955 9945482
Fung TS Chakrabarti R Higgs HN The multiple links between actin and mitochondria Nat. Rev. Mol. Cell Biol. 2023 24 651 667 1:CAS:528:DC%2BB3sXhtFKktbvJ 10.1038/s41580-023-00613-y 37277471 10528321
Altieri DC Mitochondrial dynamics and metastasis Cell. Mol. Life Sci. 2019 76 827 835 1:CAS:528:DC%2BC1cXitFOjtLzM 10.1007/s00018-018-2961-2 30415375
Ghosh JC et al. Ghost mitochondria drive metastasis through adaptive GCN2/Akt therapeutic vulnerability Proc. Natl. Acad. Sci. U.S.A. 2022 119 e2115624119 1:CAS:528:DC%2BB38Xmtl2ht7c%3D 10.1073/pnas.2115624119 35177476 8872753
Caino MC et al. Syntaphilin controls a mitochondrial rheostat for proliferation-motility decisions in cancer J. Clin. Invest. 2017 127 3755 3769 2017frfi.book...C 10.1172/JCI93172 28891816 5617650
Agarwal E et al. Myc regulation of a mitochondrial trafficking network mediates tumor cell invasion and metastasis Mol. Cell. Biol. 2019 39 e00109 19 1:CAS:528:DC%2BC1MXhvFWms7bL 10.1128/MCB.00109-19 31061095 6597883
Li G-B et al. Mitochondrial fission and mitophagy depend on cofilin-mediated actin depolymerization activity at the mitochondrial fission site Oncogene 2018 43 95 1:CAS:528:DC%2BC1cXisFeitbfJ
Blackstone BN et al. Myoferlin depletion elevates focal adhesion kinase and paxillin phosphorylation and enhances cell-matrix adhesion in breast cancer cells Am. J. Physiol. Cell Physiol. 2015 308 C642 9 1:CAS:528:DC%2BC2MXnvFGlsLc%3D 10.1152/ajpcell.00276.2014 25631868
Volakis LI et al. Loss of myoferlin redirects breast cancer cell motility towards collective migration PLoS ONE 2014 9 e86110 2014PLoSO..986110V 10.1371/journal.pone.0086110 24586247 3935829
Zhang W Zhou P Meng A Zhang R Zhou Y Down-regulating Myoferlin inhibits the vasculogenic mimicry of melanoma via decreasing MMP-2 and inducing mesenchymal-to-epithelial transition J. Cell. Mol. Med. 2017 155 739
Demonbreun AR et al. Myoferlin is required for insulin-like growth factor response and muscle growth Faseb J. 2010 24 1284 1295 1:CAS:528:DC%2BC3cXktlOqtrY%3D 10.1096/fj.09-136309 20008164 2845429
Ezratty EJ Bertaux C Marcantonio EE Gundersen GG Clathrin mediates integrin endocytosis for focal adhesion disassembly in migrating cells J. Cell Biol. 2009 187 733 747 1:CAS:528:DC%2BD1MXhsFeksr7I 10.1083/jcb.200904054 19951918 2806590
Chen X et al. hnRNPLL regulates MYOF alternative splicing and correlates with early metastasis in pancreatic ductal adenocarcinoma Cancer Lett. 2025 611 217436 1:CAS:528:DC%2BB2MXhtVKisr0%3D 10.1016/j.canlet.2024.217436
Blomme A et al. Myoferlin regulates cellular lipid metabolism and promotes metastases in triple-negative breast cancer Oncogene 2017 36 2116 2130 1:CAS:528:DC%2BC28XhslWhtrnI 10.1038/onc.2016.369 27775075
Li Z et al. Targeting MYOF suppresses pancreatic ductal adenocarcinoma progression by inhibiting ILF3-LCN2 signaling through disrupting OTUB1-mediated deubiquitination of ILF3 Redox Biol. 2025 84 103665 1:CAS:528:DC%2BB2MXht1CnsLjM 10.1016/j.redox.2025.103665 40381229 12145718
Gu H et al. Discovery of a highly potent and selective MYOF inhibitor with improved water solubility for the treatment of gastric cancer J. Med. Chem. 2023 66 16917 16938 1:CAS:528:DC%2BB3sXisFehsLvM 10.1021/acs.jmedchem.3c01639 38054798
